Akili, Inc. (AKLI)
Jul 2, 2024 - AKLI was delisted (reason: acquired by Virtual Therapeutics)
0.433
+0.001 (0.25%)
Inactive · Last trade price
on Jul 1, 2024
Akili Stock Forecast
AKLI's stock price has decreased by -60.98% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Akili stock has a target of 4.00, which predicts an increase of 823.57% from the current stock price of 0.43.
Analyst Consensus: Buy
* Price targets were last updated on Aug 11, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for Akili is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '23 | Apr '23 | May '23 | Jun '23 | Jul '23 | Aug '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Credit Suisse | Credit Suisse | Buy Reiterates $4 | Buy | Reiterates | $4 | +823.57% | Aug 11, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $2 → $3 | Hold | Maintains | $2 → $3 | +592.68% | Jan 25, 2023 |
| Morgan Stanley | Morgan Stanley | Hold Initiates $2 | Hold | Initiates | $2 | +361.79% | Dec 28, 2022 |
| B of A Securities | B of A Securities | Hold Initiates $2 | Hold | Initiates | $2 | +361.79% | Nov 18, 2022 |
| Credit Suisse | Credit Suisse | Buy Maintains $4 → $4.5 | Buy | Maintains | $4 → $4.5 | +939.02% | Nov 15, 2022 |
Financial Forecast
Revenue This Year
3.67M
from 1.68M
Increased by 118.83%
Revenue Next Year
5.71M
from 3.67M
Increased by 55.56%
EPS This Year
-0.52
from -0.76
EPS Next Year
-0.47
from -0.52
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 3.8M | 5.9M | 9.0M | |
| Avg | 3.7M | 5.7M | 8.7M | |
| Low | 3.5M | 5.5M | 8.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 125.3% | 60.1% | 57.1% | |
| Avg | 118.8% | 55.6% | 52.6% | |
| Low | 110.3% | 49.5% | 46.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -0.54 | -0.48 | -0.49 | |
| Avg | -0.52 | -0.47 | -0.48 | |
| Low | -0.50 | -0.45 | -0.46 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.